yankeesince59
"Oh Captain, my Captain".
- Joined
- Jul 7, 2013
- Messages
- 31,099
- Likes
- 13,851
- Points
- 113
...to be what we've been hoping for. I know it's early and I know it's not a vaccine but here's to hoping this will at least save some lives;
https://www.nbcnews.com/health/heal...remdesivir-shows-promise-large-trial-n1195171
Gilead Sciences reports positive drug results for remdesivir as coronavirus treatment
Pharmaceutical company Gilead Sciences on Wednesday reported potentially encouraging results from a trial for a drug that's being tested as a treatment for the coronavirus.
Gilead said that the antiviral drug remdesivir produced "similar improvement" in patients over a 10-day treatment plan compared with a five-day treatment plan – and that it recorded "no new safety" issues among hospitalized patients who "well-tolerated" the treatment in the study.
“The study demonstrates the potential for some patients to be treated with a 5-day regimen, which could significantly expand the number of patients who could be treated with our current supply of remdesivir," said Merdad Parsey, chief medical officer of Gilead Sciences, in a statement. "This is particularly important in the setting of a pandemic, to help hospitals and healthcare workers treat more patients in urgent need of care."
Gilead's stock rose 9% in premarket trading.
The initial results released Wednesday come after a report two weeks ago by the medical site STAT suggested potentially positive results in one of its remdesivir trials.
https://www.nbcnews.com/health/heal...remdesivir-shows-promise-large-trial-n1195171
Gilead Sciences reports positive drug results for remdesivir as coronavirus treatment
Pharmaceutical company Gilead Sciences on Wednesday reported potentially encouraging results from a trial for a drug that's being tested as a treatment for the coronavirus.
Gilead said that the antiviral drug remdesivir produced "similar improvement" in patients over a 10-day treatment plan compared with a five-day treatment plan – and that it recorded "no new safety" issues among hospitalized patients who "well-tolerated" the treatment in the study.
“The study demonstrates the potential for some patients to be treated with a 5-day regimen, which could significantly expand the number of patients who could be treated with our current supply of remdesivir," said Merdad Parsey, chief medical officer of Gilead Sciences, in a statement. "This is particularly important in the setting of a pandemic, to help hospitals and healthcare workers treat more patients in urgent need of care."
Gilead's stock rose 9% in premarket trading.
The initial results released Wednesday come after a report two weeks ago by the medical site STAT suggested potentially positive results in one of its remdesivir trials.




are largely unknown at this point